Exact Mass: 281.1528

Exact Mass Matches: 281.1528

Found 31 metabolites which its exact mass value is equals to given mass value 281.1528, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

phentolamine

phentolamine

C17H19N3O (281.1528)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

Phentolamine

3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol

C17H19N3O (281.1528)


Phentolamine is only found in individuals that have used or taken this drug. It is a nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of raynaud disease and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease (PubChem). Phentolamine produces its therapeutic actions by competitively blocking alpha-adrenergic receptors (primarily excitatory responses of smooth muscle and exocrine glands), leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. The action of phentolamine on the alpha adrenergic receptors is relatively transient and the blocking effect is incomplete. The drug is more effective in antagonizing responses to circulating epinephrine and/or norepinephrine than in antagonizing responses to mediator released at the adrenergic nerve ending. Phentolamine also stimulates β-adrenergic receptors and produces a positive inotropic and chronotropic effect on the heart and increases cardiac output. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

8-hydroxymirtazapine

5-methyl-2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(19),8,10,12,15,17-hexaen-17-ol

C17H19N3O (281.1528)


8-hydroxymirtazapine is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

mirtazapine-N-oxide

5-methyl-2,5λ⁵,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaen-5-one

C17H19N3O (281.1528)


mirtazapine-N-oxide is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

Piberaline

1-benzyl-4-(pyridine-2-carbonyl)piperazine

C17H19N3O (281.1528)


   
   

8-Hydroxymirtazapine

8-hydroxy Mirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3712 CONFIDENCE standard compound; INTERNAL_ID 1555

   
   

8-OH-Mirtazapine

8-Hydroxymirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; INTERNAL_ID 1555

   

Piberaline

Piberaline

C17H19N3O (281.1528)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

C17H19N3O (281.1528)


   

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

C17H19N3O (281.1528)


   
   

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

C17H19N3O (281.1528)


   

Ofornine

piperidin-1-yl-[2-(pyridin-4-ylamino)phenyl]methanone

C17H19N3O (281.1528)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

   

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

C17H19N3O (281.1528)


   

Mirtazapine N-Oxide

Mirtazapine N-Oxide

C17H19N3O (281.1528)


   

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

C17H19N3O (281.1528)


   

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

C17H19N3O (281.1528)


   

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

C17H19N3O (281.1528)


   

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

C17H19N3O (281.1528)


   

8-Hydroxymirtazapine, (R)-

8-Hydroxymirtazapine, (R)-

C17H19N3O (281.1528)


   

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

C17H19N3O (281.1528)


   

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

C17H19N3O (281.1528)


   

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

C17H19N3O (281.1528)


   

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

C17H19N3O (281.1528)


   

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

C17H19N3O (281.1528)


   

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)